Top Markets
Coin of the day
Dong-A ST Co., Ltd. Dong-A ST Co., Ltd.

Dong-A ST Co., Ltd.

170900
Ранг среди акций #17345
Dong-A ST Co., Ltd. is a global enterprise focused on the research,... Dong-A ST Co., Ltd. is a global enterprise focused on the research, development, production, and commercialization of a broad spectrum of pharmaceutical products and medical devices. The company's diverse portfolio of ethical drugs targets various medical conditions, including tuberculosis (with treatments like Closerin and Terizidone), neutropenia in chemotherapy patients (such as Dulastin and Leucostim), and anemia stemming from chronic renal failure (Eporon). Its robust oncology offerings feature Gemcit for cancers affecting the lung, pancreas, breast, bladder, and ovaries; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; and Monotaxel, indicated for breast, prostate, head, neck, and gastric adenocarcinoma, among others. Additionally, Dong-A ST provides solutions for infertility and anovulation (Gonadopin), growth hormone deficiency and idiopathic short stature (Growtropin II), functional dyspepsia (Motilitone), gastritis (Stillen), diabetes (Suganon), and erectile dysfunction (Zydena). The company also actively participates in pharmaceutical licensing, encompassing both the acquisition and out-licensing of drugs. Its medical device segment includes advanced technological equipment, customized products, and specialized artificial cardiac circuit sets essential for complex open-heart surgeries. Dong-A ST Co., Ltd. was established in 1932 and is headquartered in Seoul, South Korea.
Цена акции
$25.52
Рыночная капитализация
$246.07M
Изменение (1 день)
-2.25%
Изменение (1 год)
-4.13%
Страна
KR
Торговля Dong-A ST Co., Ltd. (170900)

Категория

Коэффициент P/B для Dong-A ST Co., Ltd. (170900)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Dong-A ST Co., Ltd., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Dong-A ST Co., Ltd. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов